Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis

BACKGROUND: The clinical context for using blood eosinophil (EOS) counts as treatment–response biomarkers in asthma and COPD requires better understanding of EOS distributions and ranges. We describe EOS distributions and ranges published in asthma, COPD, control (non-asthma/COPD) and general popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Benson, Victoria S., Hartl, Sylvia, Barnes, Neil, Galwey, Nicholas, Van Dyke, Melissa K., Kwon, Namhee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756293/
https://www.ncbi.nlm.nih.gov/pubmed/34172466
http://dx.doi.org/10.1183/13993003.04590-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756293/
https://www.ncbi.nlm.nih.gov/pubmed/34172466
http://dx.doi.org/10.1183/13993003.04590-2020

Ejemplares similares